Facebook Linkedin RSS Twitter Youtube
Home 2024

Cancers

Lymphoma Immunotherapy Enhanced by Enzyme Inhibitor In Preclinical Model, Prompting Pilot Clinical Studies
Cancer

Lymphoma Immunotherapy Enhanced by Enzyme Inhibitor In Preclinical Model, Prompting Pilot Clinical Studies

Killer T Cells Programmed for Tissue- and Tumor-Specific Targeting
Cancer

Killer T Cells Programmed for Tissue- and Tumor-Specific Targeting

Urine—Its Revolutionary Potential as a Liquid Biopsy Sample
Cancer

Urine—Its Revolutionary Potential as a Liquid Biopsy Sample

Potential Cancer Target Uncovered in Bacterial Toxin
Cancer

Potential Cancer Target Uncovered in Bacterial Toxin

Tumors Have a Taste for Fructose, If It’s Transformed by the Liver
Cancer

Tumors Have a Taste for Fructose, If It’s Transformed by the Liver

Cancer Immunotherapy Could Turn Up the Heat on Cold Tumors by Suppressing UBA1
Cancer

Cancer Immunotherapy Could Turn Up the Heat on Cold Tumors by Suppressing UBA1

Stem Cell Behavior Influenced by PIEZO-Dependent Mechanosensing
News

Stem Cell Behavior Influenced by PIEZO-Dependent Mechanosensing

CAR T Cells Armed with IL-15 Show Promise in Solid Cancer Therapy
Cancer

CAR T Cells Armed with IL-15 Show Promise in Solid Cancer Therapy

Triggering Necroptosis in Tumor Cells Can Backfire in a Cloud of IL-1a
Cancer

Triggering Necroptosis in Tumor Cells Can Backfire in a Cloud of IL-1a

Gene Signature for High-Risk Form of Acute Lymphoblastic Leukemia Identified by CHOP Scientists
Cancer

Gene Signature for High-Risk Form of Acute Lymphoblastic Leukemia Identified by CHOP Scientists

1234...759Page 3 of 759
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.